EarlyExo
Interventional, international, multi-center, prospective, controlled, randomized with blinded outcome assessment
Discover EarlyExo, the first benefit study to investigate the effectiveness of using Atalante for rehabilitation in clinical routine in patients with severe hemiparesis, compared to standard rehabilitation management.
You will read in this study
> The target population
> Primary objective
> Secondary objectives
Rebecca SAUVAGNAC
Physiatrist and clinical director at Wandercraft
"Gait training exoskeletons, such as Atalante X, are innovative tools in the management of people with walking impairment. They maximize rehabilitation training; in the hope of improving recovery after a neurological lesion; and in preventing the appearance of complications secondary to prolonged immobilization. Clinical studies comparing Atalante to conventional rehabilitation are undergoing to prove the potential clinical benefits.
In the long term and taking into consideration the current progress in terms of the management of Neurological lesions, particularly with the appearance of new treatments that give hope of repairing or supplementing the nervous system, exoskeletons have their place in maintaining the body in a state of general good health for people in wheelchairs."